ATA305683A - Verfahren zur herstellung von neuen n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylid n)-n-methylmethan - Google Patents

Verfahren zur herstellung von neuen n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylid n)-n-methylmethan

Info

Publication number
ATA305683A
ATA305683A AT833056A AT305683A ATA305683A AT A305683 A ATA305683 A AT A305683A AT 833056 A AT833056 A AT 833056A AT 305683 A AT305683 A AT 305683A AT A305683 A ATA305683 A AT A305683A
Authority
AT
Austria
Prior art keywords
propenylide
methylmethane
pyridinyl
dimethylamino
producing new
Prior art date
Application number
AT833056A
Other languages
English (en)
Other versions
AT380236B (de
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of ATA305683A publication Critical patent/ATA305683A/de
Application granted granted Critical
Publication of AT380236B publication Critical patent/AT380236B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0305683A 1980-02-26 1983-08-26 Verfahren zur herstellung von neuen n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylid n)-n-methylmethan iminiumsalzen AT380236B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic
AT0088581A AT380237B (de) 1980-02-26 1981-02-25 Verfahren zur herstellung von 5-(cyan- oder carbamyl)-(3,4'-bipyridin)-6(1h)-on

Publications (2)

Publication Number Publication Date
ATA305683A true ATA305683A (de) 1985-09-15
AT380236B AT380236B (de) 1986-04-25

Family

ID=22416880

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0088581A AT380237B (de) 1980-02-26 1981-02-25 Verfahren zur herstellung von 5-(cyan- oder carbamyl)-(3,4'-bipyridin)-6(1h)-on
AT0305683A AT380236B (de) 1980-02-26 1983-08-26 Verfahren zur herstellung von neuen n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylid n)-n-methylmethan iminiumsalzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0088581A AT380237B (de) 1980-02-26 1981-02-25 Verfahren zur herstellung von 5-(cyan- oder carbamyl)-(3,4'-bipyridin)-6(1h)-on

Country Status (28)

Country Link
US (1) US4264609A (de)
JP (1) JPS56128758A (de)
KR (2) KR840002067B1 (de)
AR (1) AR230630A1 (de)
AT (2) AT380237B (de)
AU (1) AU541644B2 (de)
BE (1) BE887663A (de)
CA (1) CA1128523A (de)
CH (1) CH647509A5 (de)
DE (1) DE3107306A1 (de)
DK (1) DK171253B1 (de)
ES (1) ES499776A1 (de)
FI (1) FI76787C (de)
FR (1) FR2476646A1 (de)
GB (1) GB2070600B (de)
HK (1) HK71789A (de)
IE (1) IE51696B1 (de)
IL (1) IL62161A (de)
IT (1) IT1210992B (de)
LU (1) LU83169A1 (de)
MX (1) MX6908E (de)
NL (1) NL192109C (de)
NO (1) NO156689C (de)
NZ (1) NZ196282A (de)
PH (2) PH19904A (de)
PT (1) PT72573B (de)
SE (2) SE437514B (de)
ZA (1) ZA811124B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685840D1 (de) 1985-04-30 1992-08-06 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
NO156689B (no) 1987-07-27
NL192109C (nl) 1997-02-04
GB2070600A (en) 1981-09-09
NZ196282A (en) 1983-12-16
ES499776A1 (es) 1984-06-16
KR840002066B1 (ko) 1984-11-09
US4264609A (en) 1981-04-28
PH17145A (en) 1984-06-04
SE437514B (sv) 1985-03-04
AT380236B (de) 1986-04-25
AU6748781A (en) 1981-09-03
SE8402727L (sv) 1984-05-21
PT72573B (en) 1982-02-12
AR230630A1 (es) 1984-05-31
NO156689C (no) 1987-11-04
IL62161A0 (en) 1981-03-31
KR840002067B1 (ko) 1984-11-09
IT8119952A0 (it) 1981-02-24
AU541644B2 (en) 1985-01-17
DK171253B1 (da) 1996-08-12
SE8402727D0 (sv) 1984-05-21
PH19904A (en) 1986-08-13
CH647509A5 (fr) 1985-01-31
ZA811124B (en) 1982-03-31
PT72573A (pt) 1981-03-01
NO810639L (no) 1981-08-27
KR830005143A (ko) 1983-08-03
DE3107306C2 (de) 1990-11-29
SE452764B (sv) 1987-12-14
HK71789A (en) 1989-09-14
DE3107306A1 (de) 1981-12-17
ATA88581A (de) 1985-09-15
IL62161A (en) 1984-06-29
MX6908E (es) 1986-11-07
FI76787C (fi) 1988-12-12
SE8101205L (sv) 1981-08-27
FR2476646A1 (fr) 1981-08-28
FR2476646B1 (de) 1984-08-17
FI76787B (fi) 1988-08-31
AT380237B (de) 1986-04-25
BE887663A (fr) 1981-08-25
LU83169A1 (fr) 1981-09-11
NL8100922A (nl) 1981-09-16
IE51696B1 (en) 1987-02-18
IT1210992B (it) 1989-09-29
DK83981A (da) 1981-08-27
NL192109B (nl) 1996-10-01
CA1128523A (en) 1982-07-27
GB2070600B (en) 1984-07-11
JPH0141626B2 (de) 1989-09-06
FI810582L (fi) 1981-08-27
IE810397L (en) 1981-08-26
JPS56128758A (en) 1981-10-08

Similar Documents

Publication Publication Date Title
AT380259B (de) Verfahren zur herstellung von neuen peptidamiden
AT379390B (de) Verfahren zur herstellung von neuen chinolonverbindungen
AT368509B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporinen
ATA427680A (de) Verfahren zur herstellung von neuen 6-pyridazinonen
AT352742B (de) Verfahren zur herstellung von neuen n-substi- tuierten lactamen
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT371482B (de) Verfahren zur herstellung von neuen 4-(substituierten) thio-1-b-d-
AT380478B (de) Verfahren zur herstellung von neuen kondensierten as-triazin-derivaten
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
AT380233B (de) Verfahren zur herstellung von neuen 1,7,7
ATA305683A (de) Verfahren zur herstellung von neuen n-(3-dimethylamino-2-(4-pyridinyl)-2-propenylid n)-n-methylmethan
AT373595B (de) Verfahren zur herstellung von neuen chinazolinen
AT368511B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
ATA425783A (de) Verfahren zur herstellung von neuen n1-(2-cyano-2-methoxy- bzw. hydorxy-imino)acetyl-n2-cycloalkylharnstoffen
ATA568979A (de) Verfahren zur herstellunag von neuen nitrosoharnstoffverbindungen
AT372947B (de) Verfahren zur herstellung von neuen trans-6oxodecahydrochinolinen
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
ATA67481A (de) Verfahren zur herstellung von neuen androstancarbothioaten
AT369370B (de) Verfahren zur herstellung von neuen n-(pyridothienopyrazol)-amiden
AT368163B (de) Verfahren zur herstellung von neuen 7alphamethoxycephalosporinen
AT371114B (de) Verfahren zur herstellung von neuen phenyliminothiadiazolinen
AT368162B (de) Verfahren zur herstellung von neuen 7alphamethyoxycephalosporinen
AT371473B (de) Verfahren zur herstellung von neuen cephalosporinantibiotika
ATA473881A (de) Verfahren zur herstellung von neuen cephalosporinantibiotika

Legal Events

Date Code Title Description
EFA Change in the company name
ELA Expired due to lapse of time